{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T21:03:23Z","timestamp":1768424603223,"version":"3.49.0"},"publisher-location":"Cham","reference-count":123,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319121130","type":"print"},{"value":"9783319121147","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T00:00:00Z","timestamp":1417651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-12114-7_2","type":"book-chapter","created":{"date-parts":[[2014,12,3]],"date-time":"2014-12-03T11:32:05Z","timestamp":1417606325000},"page":"37-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Signaling Pathways Regulating Pituitary Lactotrope Homeostasis and Tumorigenesis"],"prefix":"10.1007","author":[{"given":"Allyson K.","family":"Booth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Gutierrez-Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,4]]},"reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80:1523\u20131631.","journal-title":"Physiol Rev"},{"key":"2_CR2","doi-asserted-by":"publisher","first-page":"6926","DOI":"10.1093\/emboj\/16.23.6926","volume":"16","author":"ND Horseman","year":"1997","unstructured":"Horseman ND, Zhao W, Montecino-Rodriguez E, Tanaka M, Nakashima K, Engle SJ, Smith F, Markoff E, Dorshkind K (1997) Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J 16:6926\u20136935. doi:10.1093\/emboj\/16.23.6926","journal-title":"EMBO J"},{"key":"2_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1101\/gad.11.2.167","volume":"11","author":"CJ Ormandy","year":"1997","unstructured":"Ormandy CJ, Camus A, Barra J, Damotte D, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA (1997) Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev 11:167\u2013178","journal-title":"Genes Dev"},{"key":"2_CR4","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3168\/jds.S0022-0302(74)84985-4","volume":"57","author":"CE Grosvenor","year":"1974","unstructured":"Grosvenor CE, Whitworth N (1974) Evidence for a steady rate of secretion of prolactin following suckling in the rat. J Dairy Sci 57:900\u2013904. doi:10.3168\/jds.S0022-0302(74)84985-4","journal-title":"J Dairy Sci"},{"key":"2_CR5","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1210\/endo-82-3-623","volume":"82","author":"F Mena","year":"1968","unstructured":"Mena F, Grosvenor CE (1968) Effect of number of pups upon suckling-induced fall in pituitary prolactin concentration and milk ejection in the rat. Endocrinology 82:623\u2013626. doi:10.1210\/endo-82-3-623","journal-title":"Endocrinology"},{"key":"2_CR6","first-page":"435","volume":"63","author":"A Ignacak","year":"2012","unstructured":"Ignacak A, Kasztelnik M, Sliwa T, Korbut RA, Rajda K, Guzik TJ (2012) Prolactin\u2013not only lactotrophin. A \u201cnew\u201d view of the \u201cold\u201d hormone. J Physiol Pharmacol 63:435\u2013443","journal-title":"J Physiol Pharmacol"},{"key":"2_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/edrv.22.6.0451","volume":"22","author":"N Ben-Jonathan","year":"2001","unstructured":"Ben-Jonathan N, Hnasko R (2001) Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22:724\u2013763. doi:10.1210\/er.22.6.724","journal-title":"Endocr Rev"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1016\/S0021-9258(19)39945-4","volume":"265","author":"PR Albert","year":"1990","unstructured":"Albert PR, Neve KA, Bunzow JR, Civelli O (1990) Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. J Biol Chem 265:2098\u20132104","journal-title":"J Biol Chem"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"12007","DOI":"10.1016\/S0021-9258(17)32674-1","volume":"269","author":"AM Lew","year":"1994","unstructured":"Lew AM, Yao H, Elsholtz HP (1994) G(i) alpha 2- and G(o) alpha-mediated signaling in the Pit-1-dependent inhibition of the prolactin gene promoter. Control of transcription by dopamine D2 receptors. J Biol Chem 269:12007\u201312013","journal-title":"J Biol Chem"},{"key":"2_CR10","doi-asserted-by":"publisher","first-page":"35819","DOI":"10.1074\/jbc.M202920200","volume":"277","author":"JC Liu","year":"2002","unstructured":"Liu JC, Baker RE, Sun C, Sundmark VC, Elsholtz HP (2002) Activation of Go-coupled dopamine D2 receptors inhibits ERK1\/ERK2 in pituitary cells. A key step in the transcriptional suppression of the prolactin gene. J Biol Chem 277:35819\u201335825. doi:10.1074\/jbc.M202920200","journal-title":"J Biol Chem"},{"key":"2_CR11","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1210\/me.2001-0220","volume":"16","author":"B Banihashemi","year":"2002","unstructured":"Banihashemi B, Albert PR (2002) Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements. Mol Endocrinol 16:2393\u20132404. doi:10.1210\/me.2001-0220","journal-title":"Mol Endocrinol"},{"key":"2_CR12","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0197-0186(96)00087-3","volume":"30","author":"S Minami","year":"1997","unstructured":"Minami S, Sarkar DK (1997) Transforming growth factor-beta 1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of oestrogen-treated Fischer 344 rats. Neurochem Int 30:499\u2013506","journal-title":"Neurochem Int"},{"key":"2_CR13","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1210\/en.2005-0430","volume":"146","author":"DK Sarkar","year":"2005","unstructured":"Sarkar DK, Chaturvedi K, Oomizu S, Boyadjieva NI, Chen CP (2005) Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes. Endocrinology 146:4179\u20134188. doi:10.1210\/en.2005-0430","journal-title":"Endocrinology"},{"key":"2_CR14","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1210\/en.2004-1448","volume":"146","author":"K Chaturvedi","year":"2005","unstructured":"Chaturvedi K, Sarkar DK (2005) Mediation of basic fibroblast growth factor-induced lactotropic cell proliferation by Src-Ras-mitogen-activated protein kinase p44\/42 signaling. Endocrinology 146:1948\u20131955. doi:10.1210\/en.2004-1448","journal-title":"Endocrinology"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1210\/endo.141.3.7382","volume":"141","author":"S Hentges","year":"2000","unstructured":"Hentges S, Boyadjieva N, Sarkar DK (2000) Transforming growth factor-beta3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141:859\u2013867. doi:10.1210\/endo.141.3.7382","journal-title":"Endocrinology"},{"key":"2_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1006\/frne.2001.0220","volume":"22","author":"S Hentges","year":"2001","unstructured":"Hentges S, Sarkar DK (2001) Transforming growth factor-beta regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 22:340\u2013363. doi:10.1006\/frne.2001.0220","journal-title":"Front Neuroendocrinol"},{"key":"2_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000094307","volume":"35","author":"DK Sarkar","year":"2006","unstructured":"Sarkar DK (2006) Genesis of prolactinomas: studies using estrogen-treated animals. Front Horm Res 35:32\u201349. doi:10.1159\/000094307","journal-title":"Front Horm Res"},{"key":"2_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11102-005-5080-7","volume":"8","author":"A Spada","year":"2005","unstructured":"Spada A, Mantovani G, Lania A (2005) Pathogenesis of prolactinomas. Pituitary 8:7\u201315. doi:10.1007\/s11102-005-5080-7","journal-title":"Pituitary"},{"key":"2_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-2007-984745","volume":"25","author":"VE Beshay","year":"2007","unstructured":"Beshay VE, Beshay JE, Halvorson LM (2007) Pituitary tumors: diagnosis, management, and implications for reproduction. Semin Reprod Med 25:388\u2013401. doi:10.1055\/s-2007-984745","journal-title":"Semin Reprod Med"},{"key":"2_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613\u2013619. doi:10.1002\/cncr.20412","journal-title":"Cancer"},{"key":"2_CR21","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1126\/science.1062736","volume":"295","author":"KM Scully","year":"2002","unstructured":"Scully KM, Rosenfeld MG (2002) Pituitary development: regulatory codes in mammalian organogenesis. Science 295:2231\u20132235. doi:10.1126\/science.1062736","journal-title":"Science"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1242\/dev.125.23.4835","volume":"125","author":"N Takuma","year":"1998","unstructured":"Takuma N, Sheng HZ, Furuta Y, Ward JM, Sharma K, Hogan BL, Pfaff SL, Westphal H, Kimura S, Mahon KA (1998) Formation of Rathke\u2019s Rathke\u2019s pouch requires dual induction from the diencephalon. Development 125:4835\u20134840","journal-title":"Development"},{"key":"2_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0168-9525(98)01476-0","volume":"14","author":"DE Watkins-Chow","year":"1998","unstructured":"Watkins-Chow DE, Camper SA (1998) How many homeobox genes does it take to make a pituitary gland? Trends Genet 14:284\u2013290","journal-title":"Trends Genet"},{"key":"2_CR24","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1128\/MCB.15.5.2849","volume":"15","author":"AP Bradford","year":"1995","unstructured":"Bradford AP, Conrad KE, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A (1995) Functional interaction of c-Ets-1 and GHF-1\/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain. Mol Cell Biol 15:2849\u20132857","journal-title":"Mol Cell Biol"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1128\/MCB.17.3.1065","volume":"17","author":"AP Bradford","year":"1997","unstructured":"Bradford AP, Wasylyk C, Wasylyk B, Gutierrez-Hartmann A (1997) Interaction of Ets-1 and the POU-homeodomain protein GHF-1\/Pit-1 reconstitutes pituitary-specific gene expression. Mol Cell Biol 17:1065\u20131074","journal-title":"Mol Cell Biol"},{"key":"2_CR26","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1074\/jbc.275.5.3100","volume":"275","author":"AP Bradford","year":"2000","unstructured":"Bradford AP, Brodsky KS, Diamond SE, Kuhn LC, Liu Y, Gutierrez-Hartmann A (2000) The Pit-1 homeodomain and beta-domain interact with Ets-1 and modulate synergistic activation of the rat prolactin promoter. J Biol Chem 275:3100\u20133106. doi:10.1074\/jbc.275.5.3100","journal-title":"J Biol Chem"},{"key":"2_CR27","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1460-9568.2010.07523.x","volume":"32","author":"H Vankelecom","year":"2010","unstructured":"Vankelecom H (2010) Pituitary stem\/progenitor cells: embryonic players in the adult gland? Eur J Neurosci 32:2063\u20132081. doi:10.1111\/j.1460-9568.2010.07523.x","journal-title":"Eur J Neurosci"},{"key":"2_CR28","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.1073\/pnas.0707886105","volume":"105","author":"T Fauquier","year":"2008","unstructured":"Fauquier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson ICAF (2008) SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland. Proc Natl Acad Sci U S A 105:2907\u20132912. doi:10.1073\/pnas.0707886105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR29","doi-asserted-by":"publisher","first-page":"6332","DOI":"10.1073\/pnas.0801644105","volume":"105","author":"AS Gleiberman","year":"2008","unstructured":"Gleiberman AS, Michurina T, Encinas JM, Roig JL, Krasnov P, Balordi F, Fishell G, Rosenfeld MG, Enikolopov G (2008) Genetic approaches identify adult pituitary stem cells. Proc Natl Acad Sci U S A 105:6332\u20136337. doi:10.1073\/pnas.0801644105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR30","doi-asserted-by":"publisher","first-page":"e4815","DOI":"10.1371\/journal.pone.0004815","volume":"4","author":"M Garcia-Lavandeira","year":"2009","unstructured":"Garcia-Lavandeira M, Quereda V, Flores I, Saez C, Diaz-Rodriguez E, Japon MA, Ryan AK, Blasco MA, Dieguez C, Malumbres M, Alvarez CV (2009) A GRFa2\/Prop1\/stem (GPS) cell niche in the pituitary. PLoS ONE 4:e4815. doi:10.1371\/journal.pone.0004815","journal-title":"PLoS ONE"},{"key":"2_CR31","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1210\/en.2005-0185","volume":"146","author":"J Chen","year":"2005","unstructured":"Chen J, Hersmus N, Van Duppen V, Caesens P, Denef C, Vankelecom H (2005) The adult pituitary contains a cell population displaying stem\/progenitor cell and early embryonic characteristics. Endocrinology 146:3985\u20133998. doi:10.1210\/en.2005-0185","journal-title":"Endocrinology"},{"key":"2_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.08.018","volume":"385","author":"H Vankelecom","year":"2014","unstructured":"Vankelecom H, Chen J (2014) Pituitary stem cells: where do we stand? Mol Cell Endocrinol 385:2\u201317. doi:10.1016\/j.mce.2013.08.018","journal-title":"Mol Cell Endocrinol"},{"key":"2_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1210\/edrv-12-4-337","volume":"12","author":"LS Frawley","year":"1991","unstructured":"Frawley LS, Boockfor FR (1991) Mammosomatotropes: presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 12:337\u2013355. doi:10.1210\/edrv-12-4-337","journal-title":"Endocr Rev"},{"key":"2_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1749-6632.2010.05924.x","volume":"1220","author":"T Cuny","year":"2011","unstructured":"Cuny T, Gerard C, Saveanu A, Barlier A, Enjalbert A (2011) Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy. Ann N Y Acad Sci 1220:60\u201370. doi:10.1111\/j.1749-6632.2010.05924.x","journal-title":"Ann N Y Acad Sci"},{"key":"2_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1677\/joe.0.1340091","volume":"134","author":"RD Kineman","year":"1992","unstructured":"Kineman RD, Faught WJ, Frawley LS (1992) The ontogenic and functional relationships between growth hormone- and prolactin-releasing cells during the development of the bovine pituitary. J Endocrinol 134:91\u201396","journal-title":"J Endocrinol"},{"key":"2_CR36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1210\/endo-129-3-1221","volume":"129","author":"RD Kineman","year":"1991","unstructured":"Kineman RD, Henricks DM, Faught WJ, Frawley LS (1991) Fluctuations in the proportions of growth hormone- and prolactin-secreting cells during the bovine estrous cycle. Endocrinology 129:1221\u20131225. doi:10.1210\/endo-129-3-1221","journal-title":"Endocrinology"},{"key":"2_CR37","first-page":"1279","volume":"7","author":"KE Conrad","year":"1992","unstructured":"Conrad KE, Gutierrez-Hartmann A (1992) The ras and protein kinase A pathways are mutually antagonistic in regulating rat prolactin promoter activity. Oncogene 7:1279\u20131286","journal-title":"Oncogene"},{"key":"2_CR38","first-page":"2059","volume":"6","author":"CA Keech","year":"1992","unstructured":"Keech CA, Jackson SM, Siddiqui SK, Ocran KW, Gutierrez-Hartmann A (1992) Cyclic adenosine 3\u2032, 5\u20325\u2032-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type. Mol Endocrinol 6:2059\u20132070. doi:10.1210\/mend.6.12.1337142","journal-title":"Mol Endocrinol"},{"key":"2_CR39","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tem.2007.03.002","volume":"18","author":"A Gutierrez-Hartmann","year":"2007","unstructured":"Gutierrez-Hartmann A, Duval DL, Bradford AP (2007) ETS transcription factors in endocrine systems. Trends Endocrinol Metab 18:150\u2013158. doi:10.1016\/j.tem.2007.03.002","journal-title":"Trends Endocrinol Metab"},{"key":"2_CR40","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4161\/psb.4.10.9530","volume":"4","author":"N Tuteja","year":"2009","unstructured":"Tuteja N (2009) Signaling through G protein coupled receptors. Plant Signal Behav 4:942\u2013947","journal-title":"Plant Signal Behav"},{"key":"2_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ceb.2013.10.005","volume":"27","author":"P Penela","year":"2014","unstructured":"Penela P, Nogu\u00e9s L, Mayor F (2014) Role of G protein-coupled receptor kinases in cell migration. Curr Opin Cell Biol 27:10\u201317. doi:10.1016\/j.ceb.2013.10.005","journal-title":"Curr Opin Cell Biol"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1152\/physrev.1990.70.2.279","volume":"70","author":"SW Lamberts","year":"1990","unstructured":"Lamberts SW, Macleod RM (1990) Regulation of prolactin secretion at the level of the lactotroph. Physiol Rev 70:279\u2013318","journal-title":"Physiol Rev"},{"key":"2_CR43","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1210\/endo-129-5-2575","volume":"129","author":"LA Arbogast","year":"1991","unstructured":"Arbogast LA, Voogt JL (1991) Mechanisms of tyrosine hydroxylase regulation during pregnancy: evidence for protein dephosphorylation during the prolactin surges. Endocrinology 129:2575\u20132582. doi:10.1210\/endo-129-5-2575","journal-title":"Endocrinology"},{"key":"2_CR44","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1111\/j.1471-4159.1993.tb13394.x","volume":"60","author":"C Pasqualini","year":"1993","unstructured":"Pasqualini C, Guibert B, Leviel V (1993) Short-term inhibitory effect of estradiol on tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons in vitro. J Neurochem 60:1707\u20131713","journal-title":"J Neurochem"},{"key":"2_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0006-8993(97)01559-X","volume":"790","author":"GM Nagy","year":"1998","unstructured":"Nagy GM, DeMaria JE, Freeman ME (1998) Changes in the local metabolism of dopamine in the anterior and neural lobes but not in the intermediate lobe of the pituitary gland during nursing. Brain Res 790:315\u2013317","journal-title":"Brain Res"},{"key":"2_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000123164","volume":"32","author":"WJ De Greef","year":"1981","unstructured":"De Greef WJ, Plotsky PM, Neill JD (1981) Dopamine levels in hypophysial stalk plasma and prolactin levels in peripheral plasma of the lactating rat: effects of a simulated suckling stimulus. Neuroendocrinology 32:229\u2013233","journal-title":"Neuroendocrinology"},{"key":"2_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1210\/me.2013-1008","volume":"27","author":"D Radl","year":"2013","unstructured":"Radl D, De Mei C, Chen E, Lee H, Borrelli E (2013) Each individual isoform of the dopamine D2 receptor protects from lactotroph hyperplasia. Mol Endocrinol 27:953\u2013965. doi:10.1210\/me.2013-1008","journal-title":"Mol Endocrinol"},{"key":"2_CR48","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1038\/sj.onc.1210421","volume":"26","author":"AS Dhillon","year":"2007","unstructured":"Dhillon AS, Hagan S, Rath O, Kolch W (2007) MAP kinase signalling pathways in cancer. Oncogene 26:3279\u20133290. doi:10.1038\/sj.onc.1210421","journal-title":"Oncogene"},{"key":"2_CR49","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1210\/en.2010-1077","volume":"152","author":"M Pertuit","year":"2011","unstructured":"Pertuit M, Romano D, Zeiller C, Barlier A, Enjalbert A, Gerard C (2011) The gsp oncogene disrupts Ras\/ERK-dependent prolactin gene regulation in gsp inducible somatotroph cell line. Endocrinology 152:1234\u20131243. doi:10.1210\/en.2010-1077","journal-title":"Endocrinology"},{"key":"2_CR50","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1210\/mend.13.7.0315","volume":"13","author":"YH Wang","year":"1999","unstructured":"Wang YH, Maurer RA (1999) A role for the mitogen-activated protein kinase in mediating the ability of thyrotropin-releasing hormone to stimulate the prolactin promoter. Mol Endocrinol 13:1094\u20131104. doi:10.1210\/mend.13.7.0315","journal-title":"Mol Endocrinol"},{"key":"2_CR51","doi-asserted-by":"publisher","first-page":"51386","DOI":"10.1074\/jbc.M308372200","volume":"278","author":"D Romano","year":"2003","unstructured":"Romano D, Magalon K, Ciampini A, Talet C, Enjalbert A, Gerard C (2003) Differential involvement of the Ras and Rap1 small GTPases in vasoactive intestinal and pituitary adenylyl cyclase activating polypeptides control of the prolactin gene. J Biol Chem 278:51386\u201351394. doi:10.1074\/jbc.M308372200","journal-title":"J Biol Chem"},{"key":"2_CR52","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tibs.2006.03.009","volume":"31","author":"LO Murphy","year":"2006","unstructured":"Murphy LO, Blenis J (2006) MAPK signal specificity: the right place at the right time. Trends Biochem Sci 31:268\u2013275. doi:10.1016\/j.tibs.2006.03.009","journal-title":"Trends Biochem Sci"},{"key":"2_CR53","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1210\/mend.14.11.0551","volume":"14","author":"JJ Watters","year":"2000","unstructured":"Watters JJ, Chun TY, Kim YN, Bertics PJ, Gorski J (2000) Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol Endocrinol 14:1872\u20131881. doi:10.1210\/mend.14.11.0551","journal-title":"Mol Endocrinol"},{"key":"2_CR54","doi-asserted-by":"publisher","first-page":"24639","DOI":"10.1074\/jbc.271.40.24639","volume":"271","author":"AP Bradford","year":"1996","unstructured":"Bradford AP, Conrad KE, Tran PH, Ostrowski MC, Gutierrez-Hartmann A (1996) GHF-1\/Pit-1 functions as a cell-specific integrator of Ras signaling by targeting the Ras pathway to a composite Ets-1\/GHF-1 response element. J Biol Chem 271:24639\u201324648. doi:10.1074\/jbc.271.40.24639","journal-title":"J Biol Chem"},{"key":"2_CR55","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1093\/nar\/29.5.1251","volume":"29","author":"RE Schweppe","year":"2001","unstructured":"Schweppe RE, Gutierrez-Hartmann A (2001) Pituitary Ets-1 and GABP bind to the growth factor regulatory sites of the rat prolactin promoter. Nucleic Acids Res 29:1251\u20131260","journal-title":"Nucleic Acids Res"},{"key":"2_CR56","doi-asserted-by":"publisher","first-page":"16863","DOI":"10.1074\/jbc.M213063200","volume":"278","author":"RE Schweppe","year":"2003","unstructured":"Schweppe RE, Melton AA, Brodsky KS, Aveline LD, Resing KA, Ahn NG, Gutierrez-Hartmann A (2003) Purification and mass spectrometric identification of GA-binding protein (GABP) as the functional pituitary Ets factor binding to the basal transcription element of the prolactin promoter. J Biol Chem 278:16863\u201316872. doi:10.1074\/jbc.M213063200","journal-title":"J Biol Chem"},{"key":"2_CR57","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1210\/en.2003-0965","volume":"145","author":"S Oomizu","year":"2004","unstructured":"Oomizu S, Chaturvedi K, Sarkar DK (2004) Folliculostellate cells determine the susceptibility of lactotropes to estradiol\u2019s mitogenic action. Endocrinology 145:1473\u20131480. doi:10.1210\/en.2003-0965","journal-title":"Endocrinology"},{"key":"2_CR58","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1530\/eje.1.02213","volume":"155","author":"E Hubina","year":"2006","unstructured":"Hubina E, Nanzer AM, Hanson MR, Ciccarelli E, Losa M, Gaia D, Papotti M, Terreni MR, Khalaf S, Jordan S, Czirj\u00e1k S, Hanz\u00e9ly Z, Nagy GM, G\u00f3th MI, Grossman AB, Korbonits M (2006) Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. Eur J Endocrinol 155:371\u2013379. doi:10.1530\/eje.1.02213","journal-title":"Eur J Endocrinol"},{"key":"2_CR59","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1083\/jcb.85.3.786","volume":"85","author":"A Schonbrunn","year":"1980","unstructured":"Schonbrunn A, Krasnoff M, Westendorf JM, Tashjian AH (1980) Epidermal growth factor and thyrotropin-releasing hormone act similarly on a clonal pituitary cell strain. Modulation of hormone production and inhbition of cell proliferation. J Cell Biol 85:786\u2013797","journal-title":"J Cell Biol"},{"key":"2_CR60","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1073\/pnas.77.1.394","volume":"77","author":"LK Johnson","year":"1980","unstructured":"Johnson LK, Baxter JD, Vlodavsky I, Gospodarowicz D (1980) Epidermal growth factor and expression of specific genes: effects on cultured rat pituitary cells are dissociable from the mitogenic response. Proc Natl Acad Sci U S A 77:394\u2013398","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR61","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1210\/endo-128-4-1981","volume":"128","author":"JS Ramsdell","year":"1991","unstructured":"Ramsdell JS (1991) Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation. Endocrinology 128:1981\u20131990. doi:10.1210\/endo-128-4-1981","journal-title":"Endocrinology"},{"key":"2_CR62","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1210\/endo-126-1-472","volume":"126","author":"JS Ramsdell","year":"1990","unstructured":"Ramsdell JS (1990) Thyrotropin-releasing hormone inhibits GH4 pituitary cell proliferation by blocking entry into S phase. Endocrinology 126:472\u2013479. doi:10.1210\/endo-126-1-472","journal-title":"Endocrinology"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/endo.136.3.7867603","volume":"136","author":"R Felix","year":"1995","unstructured":"Felix R, Meza U, Cota G (1995) Induction of classical lactotropes by epidermal growth factor in rat pituitary cell cultures. Endocrinology 136:939\u2013946. doi:10.1210\/endo.136.3.7867603","journal-title":"Endocrinology"},{"key":"2_CR64","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1073\/pnas.84.16.5923","volume":"84","author":"T Nakagawa","year":"1987","unstructured":"Nakagawa T, Mabry M, de Bustros A, Ihle JN, Nelkin BD, Baylin SB (1987) Introduction of v-Ha-ras oncogene induces differentiation of cultured human medullary thyroid carcinoma cells. Proc Natl Acad Sci U S A 84:5923\u20135927","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR65","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0092-8674(85)90280-6","volume":"42","author":"D Bar-Sagi","year":"1985","unstructured":"Bar-Sagi D, Feramisco JR (1985) Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42:841\u2013848","journal-title":"Cell"},{"key":"2_CR66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.advenzreg.2006.01.004","volume":"46","author":"JA McCubrey","year":"2006","unstructured":"McCubrey JA, Steelman LS, Abrams SL, Lee JT, Chang F, Bertrand FE, Navolanic PM, Terrian DM, Franklin RA, D\u2019Assoro AB, Salisbury JL, Mazzarino MC, Stivala F, Libra M (2006) Roles of the RAF\/MEK\/ERK and PI3K\/PTEN\/AKT pathways in malignant transformation and drug resistance. Adv Enzyme Regul 46:249\u2013279. doi:10.1016\/j.advenzreg.2006.01.004","journal-title":"Adv Enzyme Regul"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"354191","DOI":"10.1155\/2012\/354191","volume":"2012","author":"I Yajima","year":"2012","unstructured":"Yajima I, Kumasaka MY, Thang ND, Goto Y, Takeda K, Yamanoshita O, Iida M, Ohgami N, Tamura H, Kawamoto Y, Kato M (2012) RAS\/RAF\/MEK\/ERK and PI3K\/PTEN\/AKT signaling in malignant melanoma progression and therapy. Dermatol Res Pract 2012:354191. doi:10.1155\/2012\/354191","journal-title":"Dermatol Res Pract"},{"key":"2_CR68","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1677\/ERC-09-0101","volume":"16","author":"D Dworakowska","year":"2009","unstructured":"Dworakowska D, Wlodek E, Leontiou CA, Igreja S, Cakir M, Teng M, Prodromou N, G\u00f3th MI, Grozinsky-Glasberg S, Gueorguiev M, Kola B, Korbonits M, Grossman AB (2009) Activation of RAF\/MEK\/ERK and PI3K\/AKT\/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Endocr Relat Cancer 16:1329\u20131338. doi:10.1677\/ERC-09-0101","journal-title":"Endocr Relat Cancer"},{"key":"2_CR69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s12020-012-9682-3","volume":"42","author":"H Rubinfeld","year":"2012","unstructured":"Rubinfeld H, Shimon I (2012) PI3K\/Akt\/mTOR and Raf\/MEK\/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocr 42:285\u2013291. doi:10.1007\/s12020-012-9682-3","journal-title":"Endocr"},{"key":"2_CR70","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.gde.2008.12.006","volume":"19","author":"FA Karreth","year":"2009","unstructured":"Karreth FA, Tuveson DA (2009) Modelling oncogenic Ras\/Raf signalling in the mouse. Curr Opin Genet Dev 19:4\u201311. doi:10.1016\/j.gde.2008.12.006","journal-title":"Curr Opin Genet Dev"},{"key":"2_CR71","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1210\/endo.136.10.7664668","volume":"136","author":"J McAndrew","year":"1995","unstructured":"McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE (1995) Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 136:4479\u20134488. doi:10.1210\/endo.136.10.7664668","journal-title":"Endocrinology"},{"key":"2_CR72","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ctrv.2003.07.007","volume":"30","author":"JA Fresno Vara","year":"2004","unstructured":"Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonz\u00e1lez-Bar\u00f3n M (2004) PI3K\/Akt signalling pathway and cancer. Cancer Treat Rev 30:193\u2013204. doi:10.1016\/j.ctrv.2003.07.007","journal-title":"Cancer Treat Rev"},{"key":"2_CR73","doi-asserted-by":"crossref","unstructured":"Vender JR, Laird MD, Dhandapani KM (2008) Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells. Neurosurgery 62:1122\u20131127; discussion 1027\u20138. doi:10.1227\/01.neu.0000325874.82999.75","DOI":"10.1227\/01.neu.0000325874.82999.75"},{"key":"2_CR74","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/2152-7806.77029","volume":"2","author":"S Sukumari-Ramesh","year":"2011","unstructured":"Sukumari-Ramesh S, Singh N, Dhandapani KM, Vender JR (2011) mTOR inhibition reduces cellular proliferation and sensitizes pituitary adenoma cells to ionizing radiation. Surg Neurol Int 2:22. doi:10.4103\/2152-7806.77029","journal-title":"Surg Neurol Int"},{"key":"2_CR75","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1210\/en.2006-0325","volume":"147","author":"D Romano","year":"2006","unstructured":"Romano D, Pertuit M, Rasolonjanahary R, Barnier J-V, Magalon K, Enjalbert A, Gerard C (2006) Regulation of the RAP1\/RAF-1\/extracellularly regulated kinase-1\/2 cascade and prolactin release by the phosphoinositide 3-kinase\/AKT pathway in pituitary cells. Endocrinology 147:6036\u20136045. doi:10.1210\/en.2006-0325","journal-title":"Endocrinology"},{"key":"2_CR76","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1517\/14728220903170675","volume":"13","author":"M Cakir","year":"2009","unstructured":"Cakir M, Grossman AB (2009) Targeting MAPK (Ras\/ERK) and PI3K\/Akt pathways in pituitary tumorigenesis. Expert Opin Ther Targets 13:1121\u20131134. doi:10.1517\/14728220903170675","journal-title":"Expert Opin Ther Targets"},{"key":"2_CR77","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1073\/pnas.89.7.2764","volume":"89","author":"E Borrelli","year":"1992","unstructured":"Borrelli E, Sawchenko PE, Evans RM (1992) Pituitary hyperplasia induced by ectopic expression of nerve growth factor. Proc Natl Acad Sci U S A 89:2764\u20132768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR78","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1210\/mend.15.4.0625","volume":"15","author":"M Roh","year":"2001","unstructured":"Roh M, Paterson AJ, Asa SL, Chin E, Kudlow JE (2001) Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol Endocrinol 15:600\u2013613. doi:10.1210\/mend.15.4.0625","journal-title":"Mol Endocrinol"},{"key":"2_CR79","doi-asserted-by":"crossref","unstructured":"Ezzat S, Zheng L, Zhu X, Wu GE, Asa SL (2002) Targeted expression of a human pituitary tumor- derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. 109:15\u201316. doi:10.1172\/JCI200214036.Introduction","DOI":"10.1172\/JCI14036"},{"key":"2_CR80","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/ncb1567","volume":"9","author":"CJ Sarkisian","year":"2007","unstructured":"Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, Chodosh LA (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9:493\u2013505. doi:10.1038\/ncb1567","journal-title":"Nat Cell Biol"},{"key":"2_CR81","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1158\/0008-5472.CAN-08-1274","volume":"68","author":"T Daikoku","year":"2008","unstructured":"Daikoku T, Hirota Y, Tranguch S, Joshi AR, DeMayo FJ, Lydon JP, Ellenson LH, Dey SK (2008) Conditional loss of uterine Pten unfailingly and rapidly induces endometrial cancer in mice. Cancer Res 68:5619\u20135627. doi:10.1158\/0008-5472.CAN-08-1274","journal-title":"Cancer Res"},{"key":"2_CR82","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1158\/0008-5472.CAN-07-3117","volume":"68","author":"K Iwanaga","year":"2008","unstructured":"Iwanaga K, Yang Y, Raso MG, Ma L, Hanna AE, Thilaganathan N, Moghaddam S, Evans CM, Li H, Cai W-W, Sato M, Minna JD, Wu H, Creighton CJ, Demayo FJ, Wistuba II, Kurie JM (2008) Pten inactivation accelerates oncogenic K-ras-initiated tumorigenesis in a mouse model of lung cancer. Cancer Res 68:1119\u20131127. doi:10.1158\/0008-5472.CAN-07-3117","journal-title":"Cancer Res"},{"key":"2_CR83","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.1038\/sj.onc.1202857","volume":"18","author":"V Gire","year":"1999","unstructured":"Gire V, Marshall CJ, Wynford-Thomas D (1999) Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras. Oncogene 18:4819\u20134832. doi:10.1038\/sj.onc.1202857","journal-title":"Oncogene"},{"key":"2_CR84","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1038\/sj.onc.1203544","volume":"19","author":"V Gire","year":"2000","unstructured":"Gire V, Marshall C, Wynford-Thomas D (2000) PI-3-kinase is an essential anti-apoptotic effector in the proliferative response of primary human epithelial cells to mutant RAS. Oncogene 19:2269\u20132276. doi:10.1038\/sj.onc.1203544","journal-title":"Oncogene"},{"key":"2_CR85","doi-asserted-by":"publisher","first-page":"6463","DOI":"10.1158\/0008-5472.CAN-08-3363","volume":"69","author":"H-Y Fan","year":"2009","unstructured":"Fan H-Y, Liu Z, Paquet M, Wang J, Lydon JP, DeMayo FJ, Richards JS (2009) Cell type-specific targeted mutations of Kras and Pten document proliferation arrest in granulosa cells versus oncogenic insult to ovarian surface epithelial cells. Cancer Res 69:6463\u20136472. doi:10.1158\/0008-5472.CAN-08-3363","journal-title":"Cancer Res"},{"key":"2_CR86","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1210\/me.2009-0251","volume":"24","author":"H-Y Fan","year":"2010","unstructured":"Fan H-Y, Richards JS (2010) Minireview: physiological and pathological actions of RAS in the ovary. Mol Endocrinol 24:286\u2013298. doi:10.1210\/me.2009-0251","journal-title":"Mol Endocrinol"},{"key":"2_CR87","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Y Shi","year":"2003","unstructured":"Shi Y, Massagu\u00e9 J (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685\u2013700","journal-title":"Cell"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1210\/endo.141.4.7419","volume":"141","author":"S Hentges","year":"2000","unstructured":"Hentges S, Pastorcic M, De A, Boyadjieva N, Sarkar DK (2000) Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation. Endocrinology 141:1528\u20131535. doi:10.1210\/endo.141.4.7419","journal-title":"Endocrinology"},{"key":"2_CR89","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1089\/104454999314863","volume":"18","author":"KN Farrow","year":"1999","unstructured":"Farrow KN, Gutierrez-Hartmann A (1999) Transforming growth factor-beta1 inhibits rat prolactin promoter activity in GH4 neuroendocrine cells. DNA Cell Biol 18:863\u2013873. doi:10.1089\/104454999314863","journal-title":"DNA Cell Biol"},{"key":"2_CR90","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1210\/me.2003-0470","volume":"18","author":"A Lacerte","year":"2004","unstructured":"Lacerte A, Lee E-H, Reynaud R, Canaff L, De Guise C, Devost D, Ali S, Hendy GN, Lebrun J-J (2004) Activin inhibits pituitary prolactin expression and cell growth through Smads, Pit-1 and menin. Mol Endocrinol 18:1558\u20131569. doi:10.1210\/me.2003-0470","journal-title":"Mol Endocrinol"},{"key":"2_CR91","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/nrc3458","volume":"13","author":"KF Harvey","year":"2013","unstructured":"Harvey KF, Zhang X, Thomas DM (2013) The Hippo pathway and human cancer. Nat Rev Cancer 13:246\u2013257. doi:10.1038\/nrc3458","journal-title":"Nat Rev Cancer"},{"key":"2_CR92","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.cub.2007.10.039","volume":"17","author":"FD Camargo","year":"2007","unstructured":"Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R, Brummelkamp TR (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 17:2054\u20132060. doi:10.1016\/j.cub.2007.10.039","journal-title":"Curr Biol"},{"key":"2_CR93","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1101\/gad.233676.113","volume":"28","author":"Q Chen","year":"2014","unstructured":"Chen Q, Zhang N, Gray RS, Li H, Ewald AJ, Zahnow CA, Pan D (2014) A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis. Genes Dev 28:432\u2013437. doi:10.1101\/gad.233676.113","journal-title":"Genes Dev"},{"key":"2_CR94","doi-asserted-by":"crossref","unstructured":"St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J, Xu T (1999) Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat Genet 21:182\u2013186. doi:10.1038\/5965","DOI":"10.1038\/5965"},{"key":"2_CR95","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11010-011-0939-6","volume":"356","author":"R Battistutta","year":"2011","unstructured":"Battistutta R, Lolli G (2011) Structural and functional determinants of protein kinase CK2\u03b1: facts and open questions. Mol Cell Biochem 356:67\u201373. doi:10.1007\/s11010-011-0939-6","journal-title":"Mol Cell Biochem"},{"key":"2_CR96","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1210\/jc.74.4.914","volume":"74","author":"HJ Karga","year":"1992","unstructured":"Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL (1992) Ras mutations in human pituitary tumors. J Clin Endocrinol Metab 74:914\u2013919. doi:10.1210\/jcem.74.4.1312542","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR97","first-page":"50","volume":"77","author":"V Herman","year":"1993","unstructured":"Herman V, Drazin NZ, Gonsky R, Melmed S (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50\u201355. doi:10.1210\/jcem.77.1.8100831","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR98","first-page":"89","volume":"78","author":"WY Cai","year":"1994","unstructured":"Cai WY, Alexander JM, Hedley-Whyte ET, Scheithauer BW, Jameson JL, Zervas NT, Klibanski A (1994) ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab 78:89\u201393. doi:10.1210\/jcem.78.1.8288721","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR99","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1530\/eje.1.02339","volume":"156","author":"A G\u00fcrlek","year":"2007","unstructured":"G\u00fcrlek A, Karavitaki N, Ansorge O, Wass JA (2007) What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics. Eur J Endocrinol 156:143\u2013153. doi:10.1530\/eje.1.02339","journal-title":"Eur J Endocrinol"},{"key":"2_CR100","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2265.2006.02735.x","volume":"66","author":"I Ewing","year":"2007","unstructured":"Ewing I, Pedder-Smith S, Franchi G, Ruscica M, Emery M, Vax V, Garcia E, Czirj\u00e1k S, Hanz\u00e9ly Z, Kola B, Korbonits M, Grossman AB (2007) A mutation and expression analysis of the oncogene BRAF in pituitary adenomas. Clin Endocrinol (Oxf) 66:348\u2013352. doi:10.1111\/j.1365-2265.2006.02735.x","journal-title":"Clin Endocrinol"},{"key":"2_CR101","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4419-1664-8_11","volume":"668","author":"D Balasubramanian","year":"2009","unstructured":"Balasubramanian D, Scacheri PC (2009) Functional studies of menin through genetic manipulation of the Men1 homolog in mice. Adv Exp Med Biol 668:105\u2013115","journal-title":"Adv Exp Med Biol"},{"key":"2_CR102","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1210\/en.2010-1250","volume":"152","author":"E Hughes","year":"2011","unstructured":"Hughes E, Huang C (2011) Participation of Akt, menin, and p21 in pregnancy-induced beta-cell proliferation. Endocrinology 152:847\u2013855. doi:10.1210\/en.2010-1250","journal-title":"Endocrinology"},{"key":"2_CR103","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1128\/MCB.24.8.3125-3131.2004","volume":"24","author":"CA Biondi","year":"2004","unstructured":"Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF, Hayward NK (2004) Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Mol Cell Biol 24:3125\u20133131","journal-title":"Mol Cell Biol"},{"key":"2_CR104","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","volume":"98","author":"JS Crabtree","year":"2001","unstructured":"Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS (2001) A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci U S A 98:1118\u20131123. doi:10.1073\/pnas.98.3.1118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1750-1172-1-38","volume":"1","author":"F Marini","year":"2006","unstructured":"Marini F, Falchetti A, Del Monte F, Carbonell Sala S, Gozzini A, Luzi E, Brandi ML (2006) Multiple endocrine neoplasia type 1. Orphanet J Rare Dis 1:38. doi:10.1186\/1750-1172-1-38","journal-title":"Orphanet J Rare Dis"},{"key":"2_CR106","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1530\/eje.0.1400573","volume":"140","author":"J Poncin","year":"1999","unstructured":"Poncin J, Stevenaert A, Beckers A (1999) Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. Eur J Endocrinol 140:573\u2013576","journal-title":"Eur J Endocrinol"},{"key":"2_CR107","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1073\/pnas.83.11.3997","volume":"83","author":"H Sakamoto","year":"1986","unstructured":"Sakamoto H, Mori M, Taira M, Yoshida T, Matsukawa S, Shimizu K, Sekiguchi M, Terada M, Sugimura T (1986) Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa. Proc Natl Acad Sci U S A 83:3997\u20134001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR108","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1210\/mend-5-11-1687","volume":"5","author":"R Gonsky","year":"1991","unstructured":"Gonsky R, Herman V, Melmed S, Fagin J (1991) Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 5:1687\u20131695. doi:10.1210\/mend-5-11-1687","journal-title":"Mol Endocrinol"},{"key":"2_CR109","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1365-2265.1998.00332.x","volume":"48","author":"I Shimon","year":"1998","unstructured":"Shimon I, Hinton DR, Weiss MH, Melmed S (1998) Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness. Clin Endocrinol (Oxf) 48:23\u201329","journal-title":"Clin Endocrinol"},{"key":"2_CR110","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1210\/jcem.84.2.5432","volume":"84","author":"X Zhang","year":"1999","unstructured":"Zhang X, Horwitz GA, Heaney AP, Nakashima M, Prezant TR, Bronstein MD, Melmed S (1999) Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas. J Clin Endocrinol Metab 84:761\u2013767","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR111","doi-asserted-by":"crossref","unstructured":"Karhu A, Aaltonen LA (2007) Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. Hum Mol Genet 16 Spec No:R73\u20139. doi:10.1093\/hmg\/ddm036","DOI":"10.1093\/hmg\/ddm036"},{"key":"2_CR112","doi-asserted-by":"crossref","unstructured":"Boikos SA, Stratakis CA (2007) Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis. Hum Mol Genet 16 Spec No:R80\u20137. doi:10.1093\/hmg\/ddm019","DOI":"10.1093\/hmg\/ddm019"},{"key":"2_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-416021-7.00001-8","volume":"106","author":"SW Davis","year":"2013","unstructured":"Davis SW, Ellsworth BS, Per\u00e9z Millan MI, Gergics P, Schade V, Foyouzi N, Brinkmeier ML, Mortensen AH, Camper SA (2013) Pituitary gland development and disease: from stem cell to hormone production. Curr Top Dev Biol 106:1\u201347. doi:10.1016\/B978-0-12-416021-7.00001-8","journal-title":"Curr Top Dev Biol"},{"key":"2_CR114","doi-asserted-by":"publisher","first-page":"5104","DOI":"10.1210\/jc.2001-012022","volume":"87","author":"SO Akintoye","year":"2002","unstructured":"Akintoye SO, Chebli C, Booher S, Feuillan P, Kushner H, Leroith D, Cherman N, Bianco P, Wientroub S, Robey PG, Collins MT (2002) Characterization of gsp-mediated growth hormone excess in the context of McCune-Albright syndrome. J Clin Endocrinol Metab 87:5104\u20135112","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR115","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1210\/jc.2009-1360","volume":"95","author":"AG Lania","year":"2010","unstructured":"Lania AG, Ferrero S, Pivonello R, Mantovani G, Peverelli E, Di Sarno A, Beck-Peccoz P, Spada A, Colao A (2010) Evolution of an aggressive prolactinoma into a growth hormone secreting pituitary tumor coincident with GNAS gene mutation. J Clin Endocrinol Metab 95:13\u201317. doi:10.1210\/jc.2009-1360","journal-title":"J Clin Endocrinol Metab"},{"key":"2_CR116","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11102-007-0082-2","volume":"11","author":"C-O Evans","year":"2008","unstructured":"Evans C-O, Moreno CS, Zhan X, McCabe MT, Vertino PM, Desiderio DM, Oyesiku NM (2008) Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses. Pituitary 11:231\u2013245. doi:10.1007\/s11102-007-0082-2","journal-title":"Pituitary"},{"key":"2_CR117","doi-asserted-by":"crossref","unstructured":"Levy A (2008) Molecular and trophic mechanisms of tumorigenesis. Endocrinol Metab Clin North Am 37:23\u201350, vii. doi:10.1016\/j.ecl.2007.10.009","DOI":"10.1016\/j.ecl.2007.10.009"},{"key":"2_CR118","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000094308","volume":"35","author":"C Cristina","year":"2006","unstructured":"Cristina C, Garc\u00eda-Tornad\u00fa I, D\u00edaz-Torga G, Rubinstein M, Low MJ, Bec\u00fa-Villalobos D (2006) Dopaminergic D2 receptor knockout mouse: an animal model of prolactinoma. Front Horm Res 35:50\u201363. doi:10.1159\/000094308","journal-title":"Front Horm Res"},{"key":"2_CR119","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","volume":"85","author":"K Nakayama","year":"1996","unstructured":"Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY (1996) Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707\u2013720","journal-title":"Cell"},{"key":"2_CR120","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/359295a0","volume":"359","author":"T Jacks","year":"1992","unstructured":"Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA (1992) Effects of an Rb mutation in the mouse. Nature 359:295\u2013300. doi:10.1038\/359295a0","journal-title":"Nature"},{"key":"2_CR121","doi-asserted-by":"publisher","first-page":"16865","DOI":"10.1073\/pnas.262499599","volume":"99","author":"KY Tsai","year":"2002","unstructured":"Tsai KY, MacPherson D, Rubinson DA, Nikitin AY, Bronson R, Mercer KL, Crowley D, Jacks T (2002) ARF mutation accelerates pituitary tumor development in Rb+\/\u2212 mice. Proc Natl Acad Sci U S A 99:16865\u201316870. doi:10.1073\/pnas.262499599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR122","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4419-1664-8_11","volume":"668","author":"D Balasubramanian","year":"2009","unstructured":"Balasubramanian D, Scacheri PC (2009) Functional studies of menin through genetic manipulation of the Men1 homolog in mice. Adv Exp Med Biol 668:105\u2013115","journal-title":"Adv Exp Med Biol"},{"key":"2_CR123","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1210\/endo.143.8.8956","volume":"143","author":"DS Moons","year":"2002","unstructured":"Moons DS, Jirawatnotai S, Parlow AF, Gibori G, Kineman RD, Kiyokawa H (2002) Pituitary hypoplasia and lactotroph dysfunction in mice deficient for cyclin-dependent kinase-4. Endocrinology 143:3001\u20133008. doi:10.1210\/endo.143.8.8956","journal-title":"Endocrinology"}],"container-title":["Advances in Experimental Medicine and Biology","Recent Advances in Prolactin Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-12114-7_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T14:59:34Z","timestamp":1722869974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-12114-7_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,4]]},"ISBN":["9783319121130","9783319121147"],"references-count":123,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-12114-7_2","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,4]]},"assertion":[{"value":"4 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}